Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-05-07, Stock:PFE, The news for the past five days is as follows:
2019-04-30: NEWS1: Alphabet Throws a Wet Blanket on Wall Street.NEWS2: US STOCKS-S&P 500 posts best four-month run in nearly 9 years; Apple jumps after hours.NEWS3: Stocks Snag Fourth Straight Monthly Win.NEWS4: Stocks Snag Fourth Straight Monthly Win.NEWS5: US STOCKS-Nasdaq retreats as Alphabet falls but Apple gains after hours.NEWS6: After Hours Most Active for Apr 30, 2019 :  AMD, COTY, ZNGA, PFE, VIPS, CVX, T, BKD, ASRT, IXUS, INTC, FB.NEWS7: After Hours Most Active for Apr 30, 2019 :  AMD, COTY, ZNGA, PFE, VIPS, CVX, T, BKD, ASRT, IXUS, INTC, FB.NEWS8: Market Close Report: NASDAQ Composite index closes at 8,095.39 down -54 points.NEWS9: Market Close Report: NASDAQ Composite index closes at 8,095.39 down -54 points.NEWS10: S&P 500 ekes out third straight record close; Nasdaq retreats after Google revenue miss.NEWS11: Dow Drug Giants Top First-Quarter Estimates; But Another Pharma Dives.NEWS12: Pfizer 1Q profit jumps 9% on higher drug sales, lower costs.NEWS13: Pfizer 1Q profit jumps 9% on higher drug sales, lower costs.NEWS14: Trump, Democratic leaders to meet on drug prices soon -White House.NEWS15: US STOCKS-Wall St's recent rally stumbles as Alphabet falls.NEWS16: U.S. Stock ETFs Stumble as Alphabet Miss Drags.NEWS17: McDonald's earnings sizzle on its bacon promotions, Alphabet's big miss, Netflix's ad destiny and Pfizer's drug pricing pressure.NEWS18: What You Need to Know About Pfizer's Q1 Earnings Beat.NEWS19: What You Need to Know About Pfizer's Q1 Earnings Beat.NEWS20: US STOCKS-Wall Street's record run hits snag after Alphabet tumbles.NEWS21: Pfizer CEO: Drug prices will not be a growth driver.NEWS22: Vaccine and blood thinner help drive Pfizer to quarterly earnings beat.NEWS23: What You Need to Know About Pfizer&apos;s Q1 Earnings Beat.NEWS24: Vaccine and blood thinner help drive Pfizer to quarterly earnings beat.NEWS25: Stocks making the biggest moves midday: Alphabet, GE, McDonald's,Texas Roadhouse & more.NEWS26: Pfizer (PFE) Beats on Q1 Earnings & Sales, Raises EPS View.NEWS27: Pfizer (PFE) Beats on Q1 Earnings & Sales, Raises EPS View.NEWS28: Big Day for Q1 Earnings: MCD, PFE, GE & More.NEWS29: Big Day for Q1 Earnings: MCD, PFE, GE & More.NEWS30: Q1 Earnings Continue.NEWS31: Q1 Earnings Continue.NEWS32: Stocks slide as Google revenue miss weighs on tech shares.NEWS33: Pfizer Lifts 2019 Earnings Forecast as Biopharma Sales Drive Q1 Profit Beat.NEWS34: Dow Movers: MMM, CVX.NEWS35: Dow Movers: MMM, CVX.NEWS36: Will Gilead Stock Get A Needed Boost From This Week’s Earnings Report?.NEWS37: Will Gilead Stock Get A Needed Boost From This Week’s Earnings Report?.NEWS38: Big Pharma Puts the Price Squeeze on Itself.NEWS39: US STOCKS-Wall Street pauses after record run as Alphabet tumbles.NEWS40: Q1 Earnings Continue.NEWS41: Merck and Pfizer Stock Rise but Eli Lilly Slips as Big Pharma Earnings Roll in.NEWS42: Big Day for Q1 Earnings: MCD, PFE, GE & More.NEWS43: Fed and tech stocks could crack the market rally, warns Wall Street strategist.NEWS44: Health Care Sector Update for 04/30/2019: LLY, PFE, NVS, JNJ, ABTX, MRK, AMGN.NEWS45: Health Care Sector Update for 04/30/2019: LLY, PFE, NVS, JNJ, ABTX, MRK, AMGN.NEWS46: Pfizer Earnings Top Estimates as New CEO Bourla Takes Reins.NEWS47: Pfizer (PFE) Beats on Q1 Earnings & Sales, Raises EPS View.NEWS48: US STOCKS-Wall Street set for mixed open, Alphabet to weigh on Nasdaq.NEWS49: Biopharmaceuticals power Pfizer in the first quarter.NEWS50: Taking A Look At Pfizer Inc.'s (NYSE:PFE) ROE.NEWS51: Pfizer, Merck Earnings Top; Eli Lilly Falls On Revenue.NEWS52: Pfizer Rises 3%.NEWS53: US STOCKS-Futures flat as investors parse latest round of earnings.NEWS54: Pfizer stock up 1.7% after earnings and revenue beat.NEWS55: Three major pharmaceutical companies just reported earnings — here&apos;s how they did.NEWS56: Three major pharmaceutical companies just reported earnings — here's how they did.NEWS57: Here's a breakdown of Big Pharma earnings from Merck, Pfizer, Eli Lilly.NEWS58: Why This Could Be the Most Dangerous Time Ever to Invest in Healthcare Stocks.NEWS59: Why This Could Be the Most Dangerous Time Ever to Invest in Healthcare Stocks.NEWS60: Pfizer, Merck both post earnings beats.NEWS61: Pfizer posts 9 pct rise in first-quarter profit.NEWS62: PFIZER REPORTS FIRST-QUARTER 2019 RESULTS.NEWS63: Why This Could Be the Most Dangerous Time Ever to Invest in Healthcare Stocks.NEWS64: Today Is Earnings Day for Big Pharma. Here’s What to Watch..NEWS65: Pfizer Earnings, Revenue Beat in Q1.
2019-05-01: NEWS1: The top 2 health care names to play for a catch-up: Technician.NEWS2: After Hours Most Active for May 1, 2019 :  GPRO, MRK, ZNGA, FITB, PFE, SQ, FCX, S, IQ, XOM, QCOM, ODP.NEWS3: After Hours Most Active for May 1, 2019 :  GPRO, MRK, ZNGA, FITB, PFE, SQ, FCX, S, IQ, XOM, QCOM, ODP.NEWS4: Dow Movers: PFE, AAPL.NEWS5: Dow Movers: PFE, AAPL.NEWS6: Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure.NEWS7: Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure.NEWS8: Health Care Sector Update for 05/01/2019: NBRV, TNDM, HUM, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 05/01/2019: NBRV, TNDM, HUM, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure.NEWS11: Pfizer Inc (PFE) Q1 2019 Earnings Call Transcript.NEWS12: Pfizer Inc (PFE) Q1 2019 Earnings Call Transcript.NEWS13: Pfizer Inc (PFE) Q1 2019 Earnings Call Transcript.NEWS14: Edited Transcript of PFE earnings conference call or presentation 30-Apr-19 2:00pm GMT.
2019-05-02: NEWS1: After Hours Most Active for May 2, 2019 :  PFE, CHK, XOM, ESV, CSTM, SRE.NEWS2: After Hours Most Active for May 2, 2019 :  PFE, CHK, XOM, ESV, CSTM, SRE.NEWS3: Pfizer Stock Rebounds Under Cloud of Negative Charts.NEWS4: Drugmakers’ lobbying spending at 10-year high as Washington targets soaring prices.NEWS5: Exelixis (EXEL) Earnings & Revenues Beat Estimates in Q1.NEWS6: Exelixis (EXEL) Earnings & Revenues Beat Estimates in Q1.NEWS7: Exelixis (EXEL) Earnings & Revenues Beat Estimates in Q1.NEWS8: Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses.NEWS9: Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses.NEWS10: Pfizer Raised Its Fiscal 2019 EPS Guidance.NEWS11: Health Care Sector Update for 05/02/2019: ABIO, CI, TFX, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 05/02/2019: ABIO, CI, TFX, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Pfizer Reiterated Its Fiscal 2019 Revenue Guidance.NEWS14: Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses.NEWS15: What Are Analysts Recommending for PFE after Q1 Results?.
2019-05-03: NEWS1: Top Stock Reports for Pfizer, Intel & HCA Healthcare.NEWS2: Top Stock Reports for Pfizer, Intel & HCA Healthcare.NEWS3: Top Stock Reports for Pfizer, Intel & HCA Healthcare.NEWS4: Health Care Sector Update for 05/03/2019: XRAY, AZN, IMGN, JNJ, PFE, ABT, MRK, AMGN.NEWS5: Health Care Sector Update for 05/03/2019: XRAY, AZN, IMGN, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV  Drugs Get EU Nod.NEWS7: Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV  Drugs Get EU Nod.NEWS8: Pfizer Reiterated Its Fiscal 2019 Expense Guidance.NEWS9: Dow 30 Stock Roundup: AAPL, PFE, MRK, MCD Earnings Impress.NEWS10: Dow 30 Stock Roundup: AAPL, PFE, MRK, MCD Earnings Impress.NEWS11: Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV  Drugs Get EU Nod.NEWS12: Dow 30 Stock Roundup: AAPL, PFE, MRK, MCD Earnings Impress.
2019-05-06: NEWS1: Exelixis Expands Its Sales.NEWS2: Exelixis Expands Its Sales.NEWS3: Conatus' (CNAT) Earnings, Revenues Miss Estimates in Q1.NEWS4: Conatus' (CNAT) Earnings, Revenues Miss Estimates in Q1.NEWS5: 7 Stocks to Buy From the T. Rowe Price Health Sciences Fund.NEWS6: 7 Stocks to Buy From the T. Rowe Price Health Sciences Fund.NEWS7: How Dow Jones&apos; Pfizer Could Take On New Drugs From 2 Biotech Stocks.NEWS8: Conatus' (CNAT) Earnings, Revenues Miss Estimates in Q1.NEWS9: Pfizer Gets FDA Approval for $225,000 Heart Disease Drug.NEWS10: Alnylam Pharmaceuticals Continues Onpattro Launch With More to Come.NEWS11: Alnylam Pharmaceuticals Continues Onpattro Launch With More to Come.NEWS12: 7 Stocks to Buy From the T. Rowe Price Health Sciences Fund.NEWS13: The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo.NEWS14: The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo.NEWS15: Pfizer gets U.S. approval for $225,000 a year heart drug.NEWS16: Health Care Sector Update for 05/06/2019: ESPR, AXSM, CANF, JNJ, PFE, ABT, MRK, AMGN.NEWS17: Health Care Sector Update for 05/06/2019: ESPR, AXSM, CANF, JNJ, PFE, ABT, MRK, AMGN.NEWS18: The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo.NEWS19: Sanofi (SNY) Ex-Dividend Date Scheduled for May 07, 2019.NEWS20: Sanofi (SNY) Ex-Dividend Date Scheduled for May 07, 2019.NEWS21: The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins.NEWS22: Pfizer gets U.S. approval for $225,000 a year heart drug.NEWS23: Pfizer gets U.S. approval for $225,000 a year heart drug.NEWS24: U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease.

Answer: Decrease